Cancer Treatment Revitalizes Elderly Patients’ Bowels for a Year
- A recent scientific study revealed that an innovative immunotherapy, originally developed to fight cancer, successfully stimulated the regeneration of intestinal cells in the elderly and significantly improved bowel...
- The treatment, developed by a team of researchers at Cold Spring Harbor Laboratory in the united States, relies on CAR-T cell technology.
- A single dose of an immunotherapy initially designed to fight cancer successfully stimulated intestinal cell regeneration and improved bowel function for up to one year in elderly individuals,...
A recent scientific study revealed that an innovative immunotherapy, originally developed to fight cancer, successfully stimulated the regeneration of intestinal cells in the elderly and significantly improved bowel function for up to a year after just one dose.
CAR-T Technology
Table of Contents
The treatment, developed by a team of researchers at Cold Spring Harbor Laboratory in the united States, relies on CAR-T cell technology.
Immunotherapy Shows Promise in Restoring Gut Health
A single dose of an immunotherapy initially designed to fight cancer successfully stimulated intestinal cell regeneration and improved bowel function for up to one year in elderly individuals, according to a study released January 24, 2026. The findings suggest potential future treatments for seniors and cancer patients experiencing gut deterioration due to age or radiation therapy.
CAR-T Technology
Researchers at Cold Spring Harbor Laboratory developed the treatment. The study, published on January 24, 2026, details how the therapy utilizes CAR-T cell technology. CAR-T (chimeric Antigen Receptor T-cell) therapy involves modifying a patient’s own immune cells to target and destroy specific cells.In this case, the therapy was adapted to stimulate regeneration rather than destruction.
Study Details & Results
- duration of Improvement: Bowel function improvements were observed for up to 12 months following a single dose.
- Cellular Impact: The therapy demonstrated similar regenerative effects in human intestinal and colon cells.
- Future research: Researchers emphasize the need for further clinical trials to confirm the therapy’s effectiveness and safety in humans.
This discovery represents a significant step toward understanding the aging of the gut and developing targeted treatments to improve quality of life for seniors. Additional clinical studies are planned to validate these findings.